John M. Lasala

John M. Lasala, MD, PhD, FACC

Top Doctors®

Specializes In
  • Cardiology
Referral Type

Physician Referral Required

Languages Spoken
  • English

Appointments

Sees Patients For

Interventional cardiology, cardiac catheterizations, coronary artery disease, circulation, angioplasty, percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction, coronary-artery stenting, Wolff-Parkinson White syndrome, ascending and descending aortic dissections, aortic aneurysms.

Hospital Affiliations

  • Barnes-Jewish Hospital

Locations

Experience

Board Certifications

  • Cardiology
  • Internal Medicine

Academic Title(s)

Professor, Medicine
Cardiovascular Division
Director, Structural Heart Disease Program

Publications & Research

Search PubMed for publications »

Education

Fellowship

1990 Intervential Cardiology, Yale University School of Medicine, New Haven, Connecticut

Fellowship

1989 Postdoctoral Cardiology, Yale University School of Medicine, New Haven, Connecticut

Residency

1986 Internal Medicine, Barnes Hospital, Washington University School of Medicine, St. Louis, Missouri

Fellowship

1979 Postdoctoral Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri

Medical Degree

University of Connecticut, Storrs, Connecticut

Ph.D.

1979 St. Louis University, St. Louis, Missouri

B.A.

1975 Drew University, Madison, New Jersey

Financial Disclosures
  • Abbott Diagnostics Inc
    • Consulting/Advisory Board: $60,000 - $79,999
    • Reporting Date: 05/01/2022
  • Abiomed
    • Equity: Yes
    • Consulting/Advisory Board: $10,000 - $19,999
    • Reporting Date: 05/01/2022
  • Boston Scientific Corporation
    • Consulting/Advisory Board: $40,000 - $59,999
    • Reporting Date: 05/01/2022
  • Gore (W. L.) and Associates
    • Consulting/Advisory Board: $10,000 - $19,999
    • Reporting Date: 05/01/2022
  • InterShunt
    • Equity: Yes
    • Reporting Date: 05/01/2022
  • Shockwave Medical
    • Consulting/Advisory Board: $20,000 - $39,999
    • Reporting Date: 05/01/2022

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.